Sort
3,198 grants matching “mrna vaccine”
Producing Recombinant mRNA in Escherichia coli
$300,518Hao Yu · E&E Bioclub Llc · R43 · FY2024 · GM
Neutralizing Antibody Core
$300,463Michael Scott Seaman · Dana-Farber Cancer Inst · P01 · FY2024 · AI
Next-generation nanomedicine for acute ischemic stroke
$300,454Jacob Brenner · Nanomuse, Llc · R41 · FY2023 · NS
Molecular mechanisms of eukaryotic translational control
$300,345Sarah Elizabeth Walker · State University Of New York At Buffalo · R01 · FY2022 · GM
Engineered T Cell Therapy for Melanoma
$300,231Robert H Vonderheide · Wistar Institute · P50 · FY2015 · CA
Genetic adjuvants to elicit neutralizing antibodies against HIV
$300,083Ellen Elizabeth Sparger · Tendel Therapies Inc. · R43 · FY2024 · MH
Bacteriophage MS2 Virus-Like Particles for Peptide Display
$300,000David S. Peabody · University Of New Mexico · R01 · FY2008 · GM
SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
$300,000Michael David Alpert · Emmune, Inc · R44 · FY2022 · AI
A Novel Multi-Epitope-Based Universal Vaccine Against Multiple Coronavirus Variants of Concern
$300,000Hawa Vahed · Techimmune, Llc · R43 · FY2024 · AI
Targeted RNA degradation assay for new antiviral drug discovery
$300,000Ryan O'Hanlon · Lucerna, Inc. · R43 · FY2024 · AI
Collaborative Research: Development of an exosome based lipoproteoplex (E-LPP) for siRNA delivery
$300,000Jin K Montclare · New York University · · FY2022 · MPS
Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individuals
$300,000Deborah L. Fuller · Orlance, Inc. · R41 · FY2025 · AI
Gene Gun-delivered RNA vaccines.
$300,000Hannah Frizzell · Orlance, Inc. · R43 · FY2025 · AI
Double-Encapsulated mRNA Vaccine for COVID-19
$300,000Trevor P. Castor · Aphios Corporation · R43 · FY2024 · AI
A Novel Multi-Epitope-Based Universal Vaccine Against Multiple Coronavirus Variants of Concern
$300,000Hawa Vahed · Techimmune, Llc · R43 · FY2023 · AI
Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection
$300,000Yanming Du · Harlingene Life Sciences Llc · R41 · FY2023 · AI
Novel anti-viral agents to treat influenza
$300,000Dipanwita Basu · Alexander Biodiscoveries, Llc · R43 · FY2010 · AI
Targeted delivery of nucleic acid formulations for in vivo CAR-Treg generation
$300,000Chester Edward Markwalter · Optimeos Life Sciences, Inc. · R43 · FY2024 · AI
Double-Encapsulated mRNA Vaccine for COVID-19
$300,000Trevor P. Castor · Aphios Corporation · R43 · FY2023 · AI
RoL: EAGER: DESYN-C3: Synthetic Biogenesis of Eukaryotic Cells
$300,000Don L Devoe · University Of Maryland, College Park · · FY2018 · ENG
Novel anti-viral agents to treat influenza
$300,000Dipanwita Basu · Alexander Biodiscoveries, Llc · R43 · FY2011 · AI
Bacteriophage MS2 Virus-Like Particles for Peptide Display
$300,000David S. Peabody · University Of New Mexico · R01 · FY2009 · GM
Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) Infection
$300,000Yanming Du · Harlingene Life Sciences Llc · R41 · FY2024 · AI
Therapy for drug resistant influenza strains by nucleic acid targeting of respiratory airways
$300,000Charles Houston Jones · Abcombi Biosciences, Inc. · R41 · FY2016 · AI
Gene Gun-delivered RNA vaccines.
$300,000Hannah Frizzell · Orlance, Inc. · R43 · FY2024 · AI